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Abstract
The production of recombinant proteins in a large scale is important for protein functional and structural studies,
particularly by using Escherichia coli over-expression systems; however, approximate 70% of recombinant proteins are over-
expressed as insoluble inclusion bodies. Here we presented an efficient method for generating soluble proteins from
inclusion bodies by using two steps of denaturation and one step of refolding. We first demonstrated the advantages of this
method over a conventional procedure with one denaturation step and one refolding step using three proteins with
different folding properties. The refolded proteins were found to be active using in vitro tests and a bioassay. We then
tested the general applicability of this method by analyzing 88 proteins from human and other organisms, all of which were
expressed as inclusion bodies. We found that about 76% of these proteins were refolded with an average of .75% yield of
soluble proteins. This ‘‘two-step-denaturing and refolding’’ (2DR) method is simple, highly efficient and generally applicable;
it can be utilized to obtain active recombinant proteins for both basic research and industrial purposes.
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Introduction
The over-expression of recombinant proteins in Escherichia coli
(E. coli) is widely used to produce proteins in large amounts, due to
noticeable advantages such as growth on inexpensive carbon
sources, rapid biomass accumulation, amenability to high cell-
density fermentation and relative ease for increasing production
scale [1–4]. However, according to the statistics in the Center for
Eukaryotic Structure Genomics (CESG) (http://targetdb.pdb.
org/statistics/sites/CESG.html), among 8048 cloned targets in
E. coli, only about 30% of them were expressed in soluble forms,
whereas the others either were degraded or formed insoluble
aggregates, known as inclusion bodies. Although inclusion bodies
cannot be directly used for studies of protein activities, their
insolubility provides an easy source of relatively pure protein, if
only such proteins can be converted to their native and active
conformation.
To obtain soluble active proteins from inclusion bodies, the
insoluble inclusion bodies need to be first solubilized in
denaturant, and then followed by a step of refolding process (for
comparison, we refer to it here as ‘‘the one-step-denaturing and
refolding’’ method) [5]. This procedure has been used over 20
years and works quite well for many inclusion body proteins, with
approximately 40% being refolded to soluble and biologically
active forms [5–7]. In this procedure, the inclusion bodies are
denatured one time by using denaturing buffer containing either
6 M guanidine hydrochloride (GdnHCl), 8 M urea, or 0.3%
sarkosyl (n-lauroyl sacosinate etc.). However, in most cases, there is
a significant amount of precipitation when refolding the proteins,
resulting in a great loss of overall yield of the target proteins.
We previously invented a new procedure called two-step-
denaturing and refolding (2DR) method, which was originally used
in 1998 to produce soluble rhG-CSF protein in a large scale
efficiently with high quality for injection [8]. This was the first time
that two denaturing steps (first GdnHCl and then urea) were used
in the same procedure. In 2005, we modified the procedure for the
hIL-2/GM-CSF inclusion body protein, with the following three
steps: (1) Denaturation with 7 M GdnHCl, (2) Removal of
GdnHCl by dialysis in 10 mM HCl buffer, (3) Addition of 8 M
urea into the solution. In this modified 2DR procedure, 10 mM
HCl was added to maintain hIL-2/GM-CSF in the soluble form
during GdnHCl removal [9]. Recently, we developed a new 2DR
procedure, which used an alkaline solution (pH.12) containing L-
arginine as the first denaturant instead of GdnHCl, and used it to
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2009, we formulated a mathematical model of refolding protein to
estimate the yield of soluble proteins from inclusion bodies by
using 2DR method [11]. At the same time, we used the Harrison’s
two-parameter prediction model [12] to predict the solubility of 43
proteins refolded from inclusion bodies, and showed by 2DR
experiments that this model could predict the refolding efficiency
of inclusion bodies [13]. However, our previous studies did not
compare the 2DR method with the conventional one-step-
denaturing and refolding method regarding the quality and
efficiency of protein refolding. Moreover, it was not clear whether
the 2DR method is generally applicable.
Hence, in this study, we compared our 2DR procedure with the
traditional one-step-denaturing and refolding method for protein
refolding from inclusion bodies. We chose three representative
proteins with different folding properties to compare the two
methods, which are enhanced green fluorescent protein (EGFP),
the catalytic domain of human macrophage metalloelastase
(MMP-12), and the DNA binding domain of neuronal restricted
silencing factor/RE-1 silencing transcription factor (NRSF/REST
DBD). Furthermore, to investigate whether the 2DR technique
can be utilized broadly on other inclusion body proteins, we
analyzed 88 insoluble inclusion body proteins for refolding to their
soluble forms by the 2DR technique.
Results
A brief description of the two-step-denaturing and
refolding (2DR) method
The first denaturing step was to thoroughly dissolve inclusion
bodies, using a denaturing buffer with 7 M GdnHCl (i.e. extraction
buffer I). Subsequently, to precipitate the GdnHCl-denatured
protein, the protein solution was diluted by the dilution buffer. The
second denaturing step was to dissolve the protein precipitate by a
denaturing buffer with 8 M urea (i.e. extraction buffer II). Then the
refolding of the target protein was conducted either on a column, or
by drop-wise dilution, or by stepwise dialysis, as described before [7].
Purification and characterization of target proteins were then carried
out by using high-resolution ion-exchange chromatography and
SDS-PAGE gel, respectively. The conformation of the refolded
proteins were monitored by acquiring circular dichroism (CD) or
NMR two-dimensional
1H-
15N HSQC spectrum; the aggregation-
states of the refolded target proteins were analyzed by either running
dynamic light scattering (DLS) experiment, or running non-
denaturing PAGE gel, or using size exclusion chromatography.
Rationale for choice of three representative proteins
To test quality and efficiency of refolding by the 2DR method
and to compare with the one-step denaturing and refolding
method, we analyzed three proteins with different folding
properties: EGFP, MMP-12, and NRSF/REST DBD (Figure
S1). EGFP was selected as a reference protein, because it could be
produced in both soluble form and insoluble inclusion bodies from
E. coli over-expression system, depending on culturing conditions
[14–15]. In addition, the green fluorescence can be used as a
sensitive assay to monitor protein folding [15]. EGFP samples
from soluble expression or refolding of inclusion bodies using
either one-step or two-step denaturing and refolding techniques
could be examined for possible difference in Circular Dichroism
(CD) and fluorescence spectrometry. MMP-12 was reported to be
over-expressed in E. coli only as inclusion bodies, and its active
form could be obtained by using the one-step denaturing and
refolding method [16–18]. So, we can test whether soluble and
active MMP-12 could be obtained by using the 2DR method and
compare the differences in the overall yield and biological activity
of soluble MMP-12 between one-step and two-step denaturing
techniques. NRSF/REST plays a critical role in neuronal gene
expression of the central nervous system (CNS) by specifically
binding to neuron restrictive regulatory elements [19–21]. It is
important to obtain soluble form of the DNA-binding domain
(DBD), which contains eight tandem zinc fingers and interacts
with nucleic acids [21], for detailed functional and structural
studies. However, there is no reported method to obtain soluble
DBD from E. coli over-expression systems. Our preliminary
analysis indicated that DBD expressed in E. coli formed inclusion
bodies and could not be refolded to soluble and biologically active
form by the one-step denaturing and refolding method. Therefore,
DBD was selected as a representative example to demonstrate the
advantages of 2DR method over one-step denaturing process.
Highly efficient production of 3 soluble proteins by 2DR
method
Both soluble form and inclusion bodies of EGFP were expressed
in E. coli. Using the 2DR method, 28 mg of pure and soluble EGFP
was successfully refolded from its inclusion bodies; this yield was
three times as much as the 9 mg obtained through the one-step
denaturing and refolding procedure, and comparable to 33 mg of
EGFP produced by soluble expression in E. coli. The refolding yield
was defined as the percentage of soluble proteins in the refolding
buffer over the amount of denatured proteins in extraction buffer II.
Because no precipitation was detected in the refolding buffer, the
overall yield of soluble EGFP was nearly 100%.
As shown in Figure 1, the maximal fluorescent intensities at
506 nm were 8162 RFU for the solubly expressed EGFP, 7738
RFU for EGFP from 2DR, 6246 RFU for EGFP from one-step
denaturing and refolding, and 269 RFU for unfolded EGFP in
extracting buffer II, all at the concentration of 1 mg/ml.
Therefore, the fluorescence absorption at 506 nm of refolded
EGFP through 2DR technique is close to that of EGFP from
soluble expression (94.8%), higher than that of 76.5% of refolded
EGFP through the one-step-denaturing and refolding procedure.
These fluorescence behaviors were consistent with the results from
CD spectra, where refolded EGFP generated using 2DR
procedure was predicted to have 22.7% (an average of three
experiments, with a range of 21–25.7) of helical structures, close to
that (32.7%) of solubly expressed EGFP, but much higher than
that (2.8%) of refolded EGFP through one-step denaturing and
refolding technique. The latter form of EGFP even had 30% of
random structure. In addition, size exclusion chromatography
demonstrated that all EGFP samples had almost the same elution
volume (about 16 ml) (Figure 2), indicating that three EGFP
samples were all monomers instead of aggregates.
MMP-12 was expressed in E. coli as inclusion bodies, and 45 mg
of soluble form was produced through the 2DR method, almost
double that the amount (23 mg) obtained from one-step denaturing
and refolding method [18]. During the refolding step, there was no
precipitation observed, so the refolding yield of MMP-12 was also
close to 100%. The biochemical activity of the refolded MMP-12




with the literature value 1.5610
5 M
21S
21 of the refolded MMP-12
obtained using the method of one-step denaturing and refolding
[17–18]. Size exclusion chromatography indicated that the two
refolded soluble MMP-12 proteins obtained from one-step and two-
step denaturing and refolding techniques, respectively, had same
elution volume of about 11 ml, suggesting that both were
monomers (Figure 2).
The DBD fragment of NRSF/REST was over-expressed in E. coli
as inclusion bodies. To obtain soluble NRSF/REST DBD from the
Two-Step-Denaturing and Refolding Technique
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technique. After several attempts, we could not obtain any soluble
DBDprotein.In contrast,wesuccessfullyrefoldedDBDtoitssoluble
and biologically active form using the 2DR technique and obtained
7 mg of pure and soluble protein. The result from size exclusion
column demonstrated that DBD was monomer, with about 15 ml of
elution volume (Figure 2). To probe whether the refolded DBD has
activity, we detected its binding affinity to NRSE/RE1 dsDNA by
using native DND PAGE gel shift binding assay [22], using unfolded
DBD as negative control (Figure 3). The native gel binding assay
indicated that the refolded DBD had binding affinity to NRSE/RE1
dsDNA, while unfolded DBD did not.
In summary, the comparison studies of EGFP, MMP-12 and DBD
demonstrated that the refolding yield with 2DR technique is
significantly better than the one-step denaturing and refolding method.
General applicability of the 2DR method
To further investigate the versatility of the 2DR technique, we
refolded 88 inclusion body proteins collected from different
laboratories in China. Among 88 inclusion body proteins (Table
S2), 27% of them were refolded to their soluble forms without any
precipitation (after centrifuging at 30,000 g) observed during
refolding, so the soluble refolding yield of these proteins was
approximately 100%; 40% of the proteins were refolded with
yields between 90% and 100%, and 9% of them with yields of 75–
90%. Only 13.6% of them were refolded to soluble form with
yields less than 50%. Accordingly, the yield of soluble proteins
refolded from inclusion bodies with more than 75% yield was
approximately 76%. These data suggested that the 2DR technique
can be widely applied to refold insoluble inclusion body proteins
with high efficiency.
Figure 1. The different behaviors of EGFP were displayed on (A) CD spectra and (B) fluorescence spectra.
doi:10.1371/journal.pone.0022981.g001
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doi:10.1371/journal.pone.0022981.g002
Figure 3. Gel shift binding assay of the refolded (left pane) and unfolded (right pane) NRSF/REST DBD.
doi:10.1371/journal.pone.0022981.g003
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In the one-step-denaturing and refolding process, either 6 M
GdnHCl or 8 M Urea denaturant is most commonly used to
solubilize the inclusion bodies in denature form [5]. Then the
denaturant should be reduced and removed from the solubilized
protein solution by dilution or dialysis in a huge volume of
refolding buffer to recover soluble and active proteins. In this step,
protein folding/unfolding intermediates are usually formed; these
intermediates often aggregate due to contiguous hydrophobic
groups [23–24]. This process of protein aggregation often leads to
a significant amount of protein precipitation, a great reduction of
overall yield of the target proteins.
In contrast, the 2DR technique emphasizes two steps of
denaturing; the first GdnHCl denaturing is to completely unfold
the misfolded protein in the inclusion bodies. However, while
GdnHCl is being removed, protein precipitation often occurs; the
second urea denaturing is designed to dissolve these protein
precipitates. From our analyses of 88 inclusion body proteins, a
key aspect of the 2DR method is to precipitate the GdnHCl-
denatured protein through dilution (especially rapid dilution), such
that as much precipitation as possible is achieved to reducing the
loss of protein in the supernatant. We also found that, if the
GdnHCl-denatured protein precipitation can be dissolved by the
second urea denaturing buffer, most likely high yielding soluble
proteins can be obtained.
According to the previous report [25–26], the inclusion bodies
formed in E. coli contain misfolded secondary protein structures,
which then lead to protein aggregation during the refolding process
of solubilizing inclusion bodies. We speculate that the first step of
strong denaturant GdnHCl of the 2DR method can unfold these
misfolded secondary structures completely into random coiled
structures. After rapid dilution of the solution containing solubilized
inclusion body protein, nearly homogeneous partially folded
intermediates might be formed as the precipitates. When the
precipitates are resolubilized by relatively mild urea denaturant, the
homogeneous partially folded intermediates would allow formation
ofcorrectstructuresinthesubsequentprotein foldingprocess.Thus,
further efforts in the feature will focus on monitoring the
conformation dynamic of protein folding pathway in the 2DR
method to determine the possible mechanism of our technique.
In conclusion, this study has shown that the 2DR method is
more efficient than the traditional one-step-denaturing and
refolding method, using the representatives EGFP, MMP-12 and
DBD proteins with different folding properties. Furthermore, the
2DR method is simple and generally applicable for diverse
insoluble proteins, it might be utilized to obtain active recombi-
nant proteins for both basic research and industrial purposes.
Materials and Methods
EGFP soluble expression and purification
The gene encoding EGFP was cloned into pTO-T7 expression
vector [27], then the plasmid was transferred into BL21 (DE3)
CodonPlus strain (Stratagene). The cells were grown in 1 liter of LB
medium at 37uC, and when the absorbance at 600 nm (OD600)
reached 0.7–0.8, a final concentration 1 mM of isopropyl-b-D-
thiogalactopyranoside (IPTG)was addedtoinducethe expressionat
16 uC for another 18 hours, then the cells were harvested at 6,000 g
at 4uC for15minutes and resuspended in40 mlofbuffer A (50 mM
Tris-HCl, 50 mM NaCl, 5 mM b-mercaptoethanol, pH 8.0). The
mixture was stirred continuously with magnetic stir bar for 1 hour
at 4uC, and then lysed by sonication on ice. The lysate was
centrifuged at 30,000 g at 4uC for 45 minutes and the resulting
clarified supernatant was collected and loaded onto a Macro-prep
High Q ion exchange column (10 ml in size, BioRad) previously
equilibrated with 50 ml of buffer A. Subsequently, the protein was
eluted out by using a linear salt gradient from 150 mM–1 M NaCl
by using buffer B (50 mM Tris-HCl, 1 M NaCl, 5 mM b-
mercaptoethanol, pH 8.0). The EGFP contained fractions were
pooled together and then purified on a DEAE column (10 ml in
size, Bio-Rad) with the two buffers same to those used on High Q
column above. The fractions including EGFP were concentrated
againbyusingaYM-10 membrane(Amicon),and thenloadedonto
a gel filtration Superdex-200 column (HiLoad
TM 16/60, GE
Healthcare Inc.) equilibrated with five columns of buffer A. Purified
EGFP was eluted out with buffer A at a flow rate of 2 ml/min, and
confirmed by SDS-PAGE gel analysis (Figure S2).
EGFP over-expression in E. coli as inclusion bodies
Using the same EGFP pTO-T7 plasmid and BL21(DE3)
CodonPlus strain above, cells were grown to OD600 of 0.7–0.8;
then 1 mM IPTG was used to induce EGFP expression at 37uC
for 4 hours. The cells were harvested at 6,000 g at 4uC for 15
minutes, washed twice with 150 ml of washing buffer I (20 mM
Tris, pH 8.0), centrifuged (30,000 g, 4uC, 30 minutes), lysed with
80 ml of buffer C (50 mM Tris, pH 8.0) by sonication on ice. The
lysate was centrifuged (30,000 g, 4uC, 45 minutes). The pellets
were cleaned twice with 150 ml of washing buffer II (50 mM Tris,
50 mM NaCl, 2% Triton X-100, 1.5 mM b-mercaptoethanol,
1.6 M urea, pH 8.0), the mixture solution was stirred for 20
minutes, centrifuged (30,000 g, 4uC, 45 minutes). To remove
Triton X-100, the inclusion bodies were further cleaned two more
times with 150 ml of washing buffer I (20 mM Tris, pH 8.0).
Finally, the pellets were kept at 220uC.
One-step denaturing and refolding of EGFP inclusion
bodies
The isolated inclusion bodies were dissolved in 5 ml of extraction
buffer II (50 mM Tris, 50 mM NaCl, 10 mM b-mercaptoethanol,
8 M urea, pH 8.0), the solution was stirred for about 20 minutes
and centrifuged (30,000 g, 4uC, 45 minutes), the supernatant was
collected and pellets were discarded. The total protein concentra-
tion in this stage was measured by using the Bradford method [28]
and adjusted to 8–10 mg/ml. Then the solution was added drop-
wise into 400 ml of refolding buffer (20 mM Tris, 1 mM EDTA,
1 mM GSH, 0.1 mM GSSG, pH 8.0) and stirred slowly with
magnetic stir bar at 4uC for two days, then loaded at a rate of
0.5 ml/min onto a Macro-prep High Q column (Bio-rad) balanced
with 50 ml of refolding buffer. The protein was eluted by using a
linear salt gradient from 150 mM–1 M NaCl in buffer D (20 mM
Tris, 1 mM EDTA, 1 M NaCl, pH 8.0), the fractions containing
EGFP were confirmed by running SDS-PAGE gel (Figure S2),
concentrated with a YM-10 membrane (Amicon), and the amount
of EGFP was determined by measuring A
280, and by using
extinction coefficient constant of 20,400 M
21 cm
21 at 280 nm
(Thermo, He ios c). Finally, to analyze the oligomeric state of
EGFP, concentrated EGFP fractions were loaded onto a Superdex-
200 column for size exclusion chromatography (Superdex
TM 10/
300GL, GE Healthcare Inc.) poised with buffer A (50 mM Tris-
HCl, 50 mM NaCl, 5 mM b-mercaptoethanol, pH 8.0) at a flow
rate of 0.5 ml/min (Figure 2).
Two-step denaturing and refolding of EGFP inclusion
bodies
The cleaned inclusion bodies were dissolved in 5 ml of
extraction buffer I (50 mM Tris, 50 mM NaCl, 10 mM b-
Two-Step-Denaturing and Refolding Technique
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centrifuged (30,000 g, 4uC, 30 minutes). The supernatant was
diluted into 200 ml of dilution buffer (50 mM Tris, 1 mM EDTA,
50 mM NaCl, 10 mM b-mercaptoethanol, pH 8.0) to rapidly
precipitate denatured EGFP, followed by centrifugation (30,000 g,
4uC, 45 minutes). The pellets were collected, and dissolved in 5 ml
of extraction buffer II (50 mM Tris-HCl, 50 mM NaCl, 10 mM
b-mercaptoethanol, 8 M urea, pH 8.0). The details for further
refolding, purification and oligomeric state determination
(Figure 2) of refolded EGFP were conducted in the same way to
those done on refolded EGFP by using one-step denaturing and
refolding technique, as described above.
Fluorescent spectra on different EGFP samples
As shown in Figure 1, to investigate the effects on the EGFP
refolding of different denaturing techniques, the fluorescence
spectra of four EGFP samples, including unfolded EGFP (negative
control), solubly expressed EGFP, two refolded EGFP from
inclusion bodies by using one-step or two-step denaturing and
refolding techniques, were adjusted to concentration of 1.0 mg/
ml. Excitation was set at 450 nm and emission spectra at 480–
570 nm were recorded using a fluorescent spectrometer Spec-
traMax M5 (Molecular Devices Inc.). Slit width was set at 2.5/
1 nm. In Figure 1B, two unfolded EGFP samples dissolved in
extracting buffer I and II were also used as negative control, which
were overlapped into a horizontal line.
Circular dichroism spectra of EGFP samples
To investigate the secondary structure contents of EGFP
samples obtained from one-step or two step denaturing techniques,
CD spectra were acquired on these samples with J-715
spectropolarimeter (Jasco), using solubly expressed EGFP as a
control. The photomultiplier voltage read never exceeded 600 V
in the spectral regions. Each spectrum was averaged from five
measurements and smoothed with spectropolarimeter system
software Jascow32. All measurements were performed at room
temperature under a nitrogen flow. The protein concentration was
50 mM. CD spectra were recorded in a 1 mm pathlength cell from
190 to 250 nm with a step size of 0.1 nm, a bandwidth of 1 nm.
CD spectrum of the appropriate buffer (1 mM Tris, pH 8.0) was
recorded and subtracted from the protein spectra. To obtain the
a-helix content of EGFP, all CD data was analyzed by using the
method of Least Squares Minimization [29–30].
MMP-12 inclusion bodies generation
The gene coding for human MMP-12 was cloned into BamH I
and Nde I sites of a T7-based expression plasmid pET11c vector
(Novagen), then the expression plasmid was transferred into the
strain BL21 (DE3). The cells were grown in 1 liter of LB medium at
37uC. When OD600 reached 0.7–0.8, protein over-expression was
induced by IPTG with a final concentration of 1 mM at 37uC for
another 4 hours, then the cells were harvested at 6,000 g at 4uC for
15 minutes, washed with 150 ml of washing buffer I, centrifuged
(30,000 g, 4uC, 30 minutes), then lysed with 80 ml of buffer C by
sonication on ice, centrifuged (30,000 g, 4uC, 45 minutes). The
supernatant was discarded, and the pellets were stored at 220uC.
Two-step denaturing and refolding of MMP-12 inclusion
bodies
The inclusion bodies were first cleaned with 150 ml of washing
buffer II, the resuspension solution was then centrifuged (30,000 g,
4uC, 30 minutes). Triton X-100 was removed by washing
precipitated denatured MMP-12 two times with 150 ml of washing
bufferI,asdidforEGFPinclusionbodies.Thentheinclusionbodies
were dissolved in 5 ml of extraction buffer I, centrifuged (30,000 g,
4uC, 30 minutes). The supernatant was diluted into 200 ml of
dilution buffer. At this point, precipitation was observed, and was
collected by centrifuging (30,000 g, 4uC, 10 minutes). The
precipitation was further dissolved in 5 ml of extraction buffer II,
then loaded onto a Sepharose Q column (5 ml in size, G.E.
Healthcare Inc.) that was previously equilibrated with 25 ml of
buffer E (50 mM Tris, 5 mM b- mercaptoethanol,6 M Ur-
ea,pH 8.0). A gradient was run from buffer E to buffer F (50 mM
Tris, 5 mM b- mercaptoethanol,6 M Urea,1 M NaCl, pH 8.0).
The MMP-12fractions wereconfirmed by running SDS-PAGE gel,
collected. To avoid precipitation shown up, the concentration of
MMP-12 was adjusted to 0.1 mg/ml, and then placed into a
MWCO 3 K dialysis membrane, and then refolded in 5 liters of
refolding buffer (20 mM Tris, 100 mM NaCl, 10 mM CaCl2,
0.2 mM ZnCl2, pH 7.5) through equal-size stepwise dialysis (Figure
S3). In this step, the refolding buffer and denaturing buffer G
(50 mM Tris, 6 M Urea, 100 mM NaCl, 10 mM CaCl2, 0.2 mM
ZnCl2, pH 7.5) were pooled in the bottles A and B, respectively.
The dialysis membrane containing MMP-12 fractions was placed in
bottle B. The flow rates of refolding buffer from bottle A into bottle
B, and of denaturing buffer G from bottle B into bottle C were
equally set as 2.2 ml/min by using pump. After dialysis was done,
the refolded MMP-12 solution was concentrated with a YM-10
membrane (Amicon). MMP-12 purity was confirmed with SDS-
PAGE gel (Figure S4). The amount of MMP-12 was calculated by
using A280 and extinction coefficient of 26930 M-1 cm-1 at
280 nm (Thermo, He ios c). Similarly, to investigate the oligomeric
state of MMP-12, size exclusion chromatography was run at a
Superdex-200 column (Superdex
TM 10/300GL, GE Healthcare
Inc.) at a flow rate of 0.5 ml/min as for EGFP (Figure 2).
The biological activity of MMP-12 catalytic domain
The activity of MMP-12 refolded with two-step denaturing
technique was measured by using the fluorescence assay, as done
in reported literature [18]. It was performed in black 96-well plates
(Corning) in a final volume of 100 ml at pH 7.4 containing:
50 mM Tris-HCl, 10 mM CaCl2, 0.05% Brij-35 (v/v), 10 mM
substrate (Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 from CAL-
BIOCHEM) and 1 nM MMP-12 at 25uC. The release of the
fluorescent product McaPL was monitored continuously using a
Genios Pro fluorescent reader, using 340 nm excitation/400 nm
emission, and calibrated to a standard curve of this compound.
Initial rates were calculated over a time period, typically 20
minutes, where the cleavage of substrate was linear with respect to
time and did not exceed 10% conversion.
DBD inclusion bodies generation
The DNA region coding for the mouse NRSF/REST DBD was
obtained through PCR amplification, and cloned into the BamH I
andNcoIsitesofaT7-based pET15bexpression plasmid (Novagen),
which was further transformed into expression strain Rosetta
2(DE3) (Merck). The cells were grown in 1 liter of LB medium at
37uC, and the expression was also induced for 4 hours with 1 mM
IPTG. The subsequent operations such as cells harvesting, washing,
resuspending, and lysing, and Triton X-1009s removing were
performed as similarly as those processed on MMP-12.
Two-step denaturing and refolding of NRSF/REST DBD
inclusion bodies
The operation details about how to denature NRSF/REST
DBD inclusion bodies firstly with 7 M GdnHCl included
Two-Step-Denaturing and Refolding Technique
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buffer II were identical with those for EGFP mentioned above.
Then NRSF/REST DBD was refolded through stepwise dialysis.
The dialysis buffer conditions were listed in Table S1. The
refolded DBD solution was loaded onto a HP Heparin column
(5 ml in size, G.E. Healthcare Inc) which was equilibrated with
25 ml of buffer H (20 mM Tris, 150 mM NaCl, 1 mM ZnCl2,
10 mM b-mercaptoethanol, pH 7.3), and the protein was eluted
out through a linear salt gradient from 150 mM - 1 M NaCl by
using buffer K (20 mM Tris, 1 M NaCl, 1 mM ZnCl2,1 0m Mb-
mercaptoethanol, pH 7.3). The identity of the protein was
confirmed by using MALDI-TOF Mass Spectroscopy and by
running SDS-PAGE gel (Figure S5). Similarly, to examine the
aggregation state of NRSF/REST DBD, size exclusion chroma-
tography was run on a Superdex-200 column (Superdex
TM 10/
300GL, GE Healthcare Inc.) at a flow rate of 0.5 ml/min as done
for EGFP (Figure 2).
Native DNA gel shift binding assay of DBD to the NRSE/
RE1 dsDNA
Each strand of NRSE/RE1 dsDNA was commercially synthe-
sized at HPLC grade (Shanghai Sangon Biological Engineering
Technology and Service Co. Ltd, China) containing the following
base sequences: 59-TTC AGC ACC ACG GAC AGC GCC-39
and 59-GGC GCT GTC CGT GGT GCT GAA-39. The DNA
binding assay was performed using a fixed concentration of 75
pmol of annealed NRSE/RE1 dsDNA. The refolded DBD was
added at the molar ratios of DBD to NRSE/RE1 dsDNA (0:1,
0.5:1, 1:1, 2:1, 3:1, respectively, as indicated from left to right in
each pane of Figure 3). The mixed solution was incubated for 30
minutes at room temperature in the final volume of 20 ul in buffer
condition: 10 mM Tris, pH 7.0, 0.1 mM ZnCl2. Then two native
DNA PAGE gels (5% polyacrylamide contained) were run, which
were further stained with EtBr to indicate the interaction results.
The unfolded DBD was used as a negative control.
Two-step denaturing and refolding of 88 inclusion
bodies proteins
The plasmids containing the genes of 88 proteins were
transferred into the BL21(DE3) strain. The cells were grown in
1 liter of LB medium at 37uC. All over-expressions were induced
by 1 mM IPTG at 37uC for 4 hours. The cells were harvested at
6,000 g at 4uC for 15 minutes, washed twice with 150 ml of
washing buffer I, centrifuged (30,000 g, 4uC, 30 minutes), lysed
with 80 ml of buffer C by sonication on ice, and centrifuged
(30,000 g, 4uC, 40 minutes). The pellets were cleaned twice with
150 ml of washing buffer II, centrifuged (30,000 g, 4uC, 30
minutes). Before being denatured, the pellets were cleaned two
times with 150 ml of washing buffer I to remove Triton X-100.
The detailed experimental operations of two-step denaturing and
refolding of these inclusion bodies were identical to those
conducted on EGFP. The purification steps of each protein were
done by using different high resolution ion-exchange chromatog-
raphy dependent on the chemical properties (such as pKa values)
of the target proteins, the identities of these proteins were
characterized by running SDS_PAGE gels and MALDI-TOF
Mass spectroscopy. Size exclusion chromatography was used to
evaluate their oligomeric states. The final results were summarized
in the Table S2.
Supporting Information
Figure S1 Schematic diagrams of NRSF/REST and its
fragment DBD construct mentioned in the paper, boxes
indicating repression domains (RD1 and RD2 in both N
and C termini) or Pro-rich domain, standing ellipses
indicating zinc fingers, lying ellipse indicating Lys-rich
region.
(DOC)
Figure S2 SDS-PAGE gel indicated EGFP production
and purification during soluble expression (A), one-step
denaturing and refolding (B) and two-step denaturing
and refolding (C) of incluison bodies. (A), line 1, Marker;
lane 2, cells before IPTG induction; lane 3, cells after IPTG
induction; lane 4, supernatant; lane 5, purified EGFP; (B) lane 1,
cells before IPTG induction; lane 2, cells after IPTG induction;
lane 3, inclusion bodies, lane 4, refolded EGFP, lane 5, marker; (C)
lane 1, cells before IPTG induction; lane 2, cells after IPTG
induction; lane 3, inclusion bodies, lane 4, refolded EGFP, lane 5,
marker.
(DOC)
Figure S3 The equipment of stepwise dialysis for MMP-
12 refolding.
(DOC)
Figure S4 SDS-PAGE gel indicated that the catalytic
domain of MMP-12 was recovered from its inclusion
bodies by using double denaturing and refolding
method. From right to left, lane 1: the cells before IPTG
introduction; lane 2, the cells after IPTG introduction; lane 3,
MMP-12 inclusion bodies; lane 4,MMP-12 in denatured buffer II ;
lane 5,refolded MMP-12; lane 6, protein marker. The molecular
weight of the catalytic domain of MMP-12 is 18.5KDa.
(DOC)
Figure S5 SDS-PAGE gel indicated DBD generation
through two-step denaturing and refolding. Lane 1,
protein marker; lane 2, cells before IPTG induction; lane 3, cells
after IPTG induction; lane 4, DBD inclusion bodies dissolved in
the extracting buffer 2; lane 5, refolded DBD.
(DOC)
Table S1 The gradient dialysis buffer for refolding DBD
from denatured buffer II.
(DOC)
Table S2 Application of two-step denaturing and re-
folding technique on 88 different inclusion bodies.
(DOC)
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